Alembic Pharmaceuticals Ltd
Sandeep Birajdar has extensive experience in regulatory affairs within the pharmaceutical industry, currently serving as Senior Manager Regulatory Affairs at Alembic Pharmaceuticals Limited since November 2015. Prior to this role, Sandeep held positions including Assistant Manager and Senior Executive at Micro Labs Limited and Strides Arcolab Limited, respectively. Sandeep began a career in regulatory affairs at PharmaLeaf India Pvt Ltd as a Junior Associate Manager. Sandeep's academic background includes an M.Pharmacy in Pharmacy-Quality Assurance from Al-Ameen College of Pharmacy and a B.Pharm in Pharmaceutical Sciences from Maharashtra College of Pharmacy Nilanga.
This person is not in any offices
Alembic Pharmaceuticals Ltd
8 followers
Alembic Pharmaceuticals Limited is a pharmaceutical company. The Company is engaged developing formulations and active pharmaceutical ingredients (API). The Company focuses on anti-infective, analgesic and, cough and cold therapies. It also focuses on therapies, such as cardiology, diabetes, gynecology, gastrointestinal, orthopedic, dermatology and ophthalmology. Its APIs include independent manufacturing blocks for Macrolides, non-steroidal anti-inflammatory drugs (NSAIDs) and other drugs. The Company offers international and domestic formulations. Under domestic formulation, it offers Branded Formulations and Generic formulations. Its domestic formulation include Roxid, Zofix, Althrocin, Tellzy AH, Revas H, Lactonic, Folinal, Gestofit, Glisen 1/2, Glimser 1/2, Veldrop, Azithral, Brinzemic and Neolap. Its generic formulations include Cetral, Ephedrex CD, Sicor, Worid, Alcephin, Alcizon, Baciclox, Comeba, Furobid, O Win Suspension, O win T, Silomag Gel, Pentab, Aginal AT and Pyremol.